Skip to content
thestock.space

On 6 Nov 2026, Max Healthcare Institute was priced at ₹934.00, or 66.1× trailing earnings, against an industry P/E of 47.7×, and the shares are 21% below their 52-week high. It earns ROCE of 13% and ROE of 13%, and sales and net profit grew 22% and 9.3% a year over 3 years. Its dividend yield is 0.2%, and debt is 0.33× equity. It is a mid-cap company with a market cap of ₹90,909 Cr, ranked 2nd of 40 Medical Care Facilities companies by market cap; the shares fell 18% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹936.90
Day high
₹936.90
Day low
₹919.40
Prev. close
₹932.00
Volume
27.6 L

Health check

1 good · 2 fair · 3 to check
  • ReturnsBehind

    −18.1% over a year, better than 1 of 7 peers.

  • Price tagPricier

    P/E 66.1 vs industry 47.7.

  • GrowthSteady

    Sales +22.4%, profit +9.3% a year over 3 years.

  • ProfitabilityAverage

    ROCE 12.6% vs peer median 11.4%.

  • Balance sheetSolid

    Debt 0.33× equity, interest covered 8.8×, Piotroski 7 of 9.

  • Red flags1 to check

    Quarterly profit down 15.5% on a year ago.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Mid cap

₹90,909 Cr, #2 of 40 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Sep 2026: sales ₹9,146 Cr · profit ₹1,381 Cr
Market cap
₹90,909 Cr
Mid cap
P/E
66.1
Industry 47.7
Price to book
8.03
Peers 8.63
Dividend yield
0.21%
ROE
12.8%
Peers 11.0%
ROCE
12.6%
Peers 11.4%
Debt to equity
0.33
Debt ₹3,795 Cr
EPS (TTM)
₹14.13
Face value ₹10
OPM (TTM)
26.8%
Net margin 15.1%
Sales growth
+20.3%
Latest quarter vs a year ago
Profit growth
−15.5%
Latest quarter vs a year ago
Price to sales
9.94
EV/EBITDA 39.5

Strengths and risks

Strengths

  • Quarterly sales up 20.3% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • Quarterly profit down 15.5% on a year ago.

Derived automatically from reported figures. Not a recommendation.

About Max Healthcare Institute

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, bone marrow transplant, bariatric/weight loss surgery, gynecology, minimal access/laparoscopic surgery, eye care/ophthalmology, robotic surgery, paediatrics, nephrology, liver and biliary…

Headquarters
Gurugram
Sector
Healthcare
ISIN
INE027H01010
Website
maxhealthcare.in

Price range

52 weeks

₹797.00₹1,185.40

Today

₹919.40₹936.90
Avg volume (3M)
29.7 L
1-year return
minus 18.1%
From 52-week high
minus 21.2%

Analyst consensus

27 analysts
BuyMean target ₹1,139.37 plus 22.0%

Target range, with today’s price

Low ₹825.00High ₹1,320.00

Next results expected around 28 Jan 2027

Consensus from Yahoo Finance. Not a recommendation.

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
KIMSKrishna Institute of Medical Sciences723.00minus 1.10%30,366138.512.878.1%11.0%19.8%21.3%−10.5%0.00%plus 2.0%
Median of 7 peers–−0.89%57,89860.48.6311.4%11.0%18.5%16.5%14.7%0.13%4.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
2,1352,0682,1432,3662,569
1,5601,5291,5361,7681,858
575538606598711
26.9%26.0%28.3%25.3%27.7%
32.945.447.840.540.9
53.959.766.77173.8
108111123132138
–−48.2–––
446365465436541
−10.1%17.5%26.3%26.0%23.4%
491301342323415
5.023.093.503.304.24

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+22.4%
Profit CAGR 3Y
+9.3%
EPS CAGR 3Y
+9.1%
ROE
12.8%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
4,4895,3096,9108,225
–+18.3%+30.2%+19.0%
3,2123,7804,9755,902
1,2771,5301,9362,324
28.5%28.8%28.0%28.3%
107150113103
71.344.6149215
232245359447
−17.2−25−134−89.2
1,0641,3651,4061,676
−3.7%22.5%23.5%13.9%
1,1041,0581,0761,442
–minus 4.2%+1.7%+34.1%
11.3610.8411.0114.76

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
971972972973
6,4397,4368,4099,774
9081,2953,0103,478
1,7842,2972,8233,006
10,10212,00015,21417,231
2,3443,8256,4967,674
3255791,034694
0.52.12.95.5
1,374980662668
6,0586,6147,0198,190
10,10212,00015,21417,231

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
1,2841,1221,4381,633
−102−1,285−1,611−1,689
−289−264−16359.3
893−428−3363.6
−336−786−944−1,485
949336493149
–−97−146−146

Shareholding pattern

Source: NSE filings

NSE hasn’t returned a shareholding pattern for this company. Institutions hold about 56.2% (Yahoo estimate).

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you